Literature DB >> 15894576

Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion.

Kenji Sampei1, John A Ulatowski, Yoshio Asano, Herman Kwansa, Enrico Bucci, Raymond C Koehler.   

Abstract

Modified Hb solutions have been developed as O(2) carrier transfusion fluids, but of concern is the possibility that increased scavenging of nitric oxide (NO) within the plasma will alter vascular reactivity even if the Hb does not readily extravasate. The effect of decreasing hematocrit from approximately 30% to 18% by an exchange transfusion of a 6% sebacyl cross-linked tetrameric Hb solution on the diameter of pial arterioles possessing tight endothelial junctions was examined through a cranial window in anesthetized cats with and without a NO synthase (NOS) inhibitor. Superfusion of a NOS inhibitor decreased diameter, and subsequent Hb transfusion produced additional constriction that was not different from Hb transfusion alone but was different from the dilation observed by exchange transfusion of an albumin solution after NOS inhibition. In contrast, abluminal application of the cross-linked Hb produced constriction that was attenuated by the NOS inhibitor. Neither abluminal nor intraluminal cross-linked Hb interfered with pial arteriolar dilation to cromakalim, an activator of ATP-sensitive potassium channels. Pial vascular reactivity to hypocapnia and hypercapnia was unaffected by Hb transfusion. Microsphere-determined regional blood flow indicated selective decreases in perfusion after Hb transfusion in the kidney, small intestine, and neurohypophysis, which does not have tight endothelial junctions. Administration of a NOS inhibitor to reduce the basal level of NO available for scavenging before Hb transfusion prevented further decreases in blood flow to these regions compared with NOS inhibition alone. In contrast, blood flow to skeletal and left ventricular muscle increased, and cerebral blood flow was unchanged after Hb transfusion. This cross-linked Hb tetramer is known to appear in renal lymph but not in urine. We conclude that cell-free tetrameric Hb does not scavenge sufficient NO in the plasma space to significantly affect baseline tone in vascular beds with tight endothelial junctions but does produce substantial constriction in beds with porous endothelium. The data support increasing the molecular size of Hb by polymerization or conjugation to limit extravasation in all vascular beds to preserve normal vascular reactivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15894576      PMCID: PMC1819403          DOI: 10.1152/ajpheart.00251.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  38 in total

1.  Production and characteristics of an infusible oxygen-carrying fluid based on hemoglobin intramolecularly cross-linked with sebacic acid.

Authors:  E Bucci; A Razynska; H Kwansa; B Matheson-Urbaitis; M O'Hearne; J A Ulatowski; R C Koehler
Journal:  J Lab Clin Med       Date:  1996-08

2.  A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation.

Authors:  Nikolaos M Tsoukias; Mahendra Kavdia; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-30       Impact factor: 4.733

3.  HbXL99 alpha: a hemoglobin derivative that is cross-linked between the alpha subunits is useful as a blood substitute.

Authors:  S R Snyder; E V Welty; R Y Walder; L A Williams; J A Walder
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  ATP-sensitive K+ channels mediate dilatation of cerebral arterioles during hypoxia.

Authors:  H Taguchi; D D Heistad; T Kitazono; F M Faraci
Journal:  Circ Res       Date:  1994-05       Impact factor: 17.367

Review 5.  No scavenging and the hypertensive effect of hemoglobin-based blood substitutes.

Authors:  John S Olson; Erin W Foley; Corina Rogge; Ah-Lim Tsai; Michael P Doyle; Douglas D Lemon
Journal:  Free Radic Biol Med       Date:  2004-03-15       Impact factor: 7.376

6.  Influence of saline infusion on blood-tissue albumin transport.

Authors:  E M Renkin; K Rew; M Wong; D O'Loughlin; L Sibley
Journal:  Am J Physiol       Date:  1989-08

7.  Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain.

Authors:  R J Traystman; L E Moore; M A Helfaer; S Davis; K Banasiak; M Williams; P D Hurn
Journal:  Stroke       Date:  1995-05       Impact factor: 7.914

8.  Positive and negative cooperativities at subsequent steps of oxygenation regulate the allosteric behavior of multistate sebacylhemoglobin.

Authors:  E Bucci; A Razynska; H Kwansa; Z Gryczynski; J H Collins; C Fronticelli; R Unger; M Braxenthaler; J Moult; X Ji; G Gilliland
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

9.  Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition.

Authors:  J A Ulatowski; T Nishikawa; B Matheson-Urbaitis; E Bucci; R J Traystman; R C Koehler
Journal:  Crit Care Med       Date:  1996-04       Impact factor: 7.598

10.  Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats.

Authors:  A C Sharma; G Singh; A Gulati
Journal:  Am J Physiol       Date:  1995-10
View more
  18 in total

Review 1.  Pre-clinical studies using OxyVita hemoglobin, a zero-linked polymeric hemoglobin: a review.

Authors:  John P Harrington; Hanna Wollocko
Journal:  J Artif Organs       Date:  2010-12-03       Impact factor: 1.731

2.  Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin.

Authors:  Xinyue Qin; Herman Kwansa; Enrico Bucci; Richard J Roman; Raymond C Koehler
Journal:  J Appl Physiol (1985)       Date:  2005-09-15

3.  Dissociation of local nitric oxide concentration and vasoconstriction in the presence of cell-free hemoglobin oxygen carriers.

Authors:  Amy G Tsai; Pedro Cabrales; Belur N Manjula; Seetharama A Acharya; Robert M Winslow; Marcos Intaglietta
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

4.  Biophysical properties and oxygenation potential of high-molecular-weight glutaraldehyde-polymerized human hemoglobins maintained in the tense and relaxed quaternary states.

Authors:  Ning Zhang; Yiping Jia; Guo Chen; Pedro Cabrales; Andre F Palmer
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

5.  Development of zero-link polymers of hemoglobin, which do not extravasate and do not induce pressure increases upon infusion.

Authors:  Enrico Bucci; Herman Kwansa; Raymond C Koehler; Barbara Matheson
Journal:  Artif Cells Blood Substit Immobil Biotechnol       Date:  2007

6.  Insensitivity of cerebral oxygen transport to oxygen affinity of hemoglobin-based oxygen carriers.

Authors:  Raymond C Koehler; Clara Fronticelli; Enrico Bucci
Journal:  Biochim Biophys Acta       Date:  2008-01-12

7.  Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias.

Authors:  Anne Jeffers; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Free Radic Biol Med       Date:  2006-08-25       Impact factor: 7.376

8.  Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin.

Authors:  Annette Rebel; Suyi Cao; Herman Kwansa; Sylvain Doré; Enrico Bucci; Raymond C Koehler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-07       Impact factor: 4.733

9.  Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse.

Authors:  Toshiaki Mito; Masaaki Nemoto; Herman Kwansa; Kenji Sampei; Murtuza Habeeb; Stephanie J Murphy; Enrico Bucci; Raymond C Koehler
Journal:  Stroke       Date:  2008-11-06       Impact factor: 7.914

10.  Key parameters affecting the initial leaky effect of hemoglobin-loaded nanoparticles as blood substitutes.

Authors:  Xiaolan Zhang; Changsheng Liu; Yuan Yuan; Shiyu Zhang; Xiaoqian Shan; Yan Sheng; Feng Xu
Journal:  J Mater Sci Mater Med       Date:  2008-01-25       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.